As our thinking about the basic principles of biology and medicine continue to evolve, the importance of context and regulatory interaction is becoming increasingly obvious. Biochemical and physiological components do not exist in isolation but instead are part of a tightly integrated network of interacting elements that ensure robustness and support the emergence of complex behavior. This integration permeates all levels of biology from gene regulation, to immune cell signaling, to coordinated patterns of neuronal activity and the resulting psychosocial interaction. Systems biology is an emerging branch of science that sits as a translational catalyst at the interface of the life and computational sciences. While there is no universally accepted definition of systems biology, we attempt to provide an overview of some the basic unifying concepts and current efforts in the field as they apply to illnesses where brain and subsequent behavior are a chief component, for example autism, schizophrenia, depression, and others. Methods in this field currently constitute a broad mosaic that stretches across multiple scales of biology and physiological compartments. While this work by no means constitutes an exhaustive list of all these methods, this work highlights the principal sub-disciplines presently driving the field as well as future directions of progress.
Introduction
The prevalence of behavioral and psychiatric disorders is increasing, and with it the cost to society. Currently, 5.4 million Americans have Alzheimer's disease requiring $200 billion in care, with the prevalence of this disease expected to double by 2050 (Alzheimer's Association, 2012). Autism now affects 1 in 88 children (Wingate et al., 2012) at an estimated annual cost of $60 billion (Järbrink and Knapp, 2001 ). An even more poorly understood illness, Chronic Fatigue Syndrome/myalgic encephalopathy (CFS/ ME), is estimated to affect 800,000 Americans and cost the US economy approximately $9.1 billion in lost productivity and up to $24 billion dollars in health care expenditures annually (Jason et al., 2008) . Clearly, the individual suffering, loss of social function, and economic cost caused by these conditions present a significant societal burden, however resolution of these illnesses is anything but simple. In a clinical setting, the classification of behavioral and psychiatric disorders remains one of the foremost challenges (Bousman and Everall, 2011) . Individuals with the same disorder often present with a broad constellation of symptoms. Likewise individuals presenting with the same symptom profile may be suffering from disparate diseases. This biological complexity creates significant challenges for standard illness classification frameworks such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (American Psychiatric Assoc., 1994) and the International Classification of Diseases (ICD-10) (World Health Org., 1992). Discovery of the molecular features that underlie these pathologies is desperately needed however in many if not most cases no single marker or identifiable lesion has been found that reliably supports screening and diagnosis of these conditions.
Reductionist approaches have and continue to serve us well on several fronts however the very breadth of symptoms and their inter-dependency pose significant challenges to this piece-wise approach. In illnesses where dysfunction spans across several of the body's main systems the issue of breadth of coverage is critical if we are to examine markers in the proper biological context. The rise of ''omic'' research (genomic, proteomic, metabolomic etc.) has lead to a rapid increase in our ability to collect and store much more comprehensive snapshots of biological processes. Indeed more data can now be collected on a single process in a year, than has been gathered over the course of scientific history (Chuang et al., 2010 ). Yet despite the growing mass of data describing genotypic variation, transcription, translation, and enzymatic biochem-0889-1591/$ -see front matter Ó 2012 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.bbi.2012.09.008
